JP2022549353A5 - - Google Patents
Info
- Publication number
- JP2022549353A5 JP2022549353A5 JP2022519324A JP2022519324A JP2022549353A5 JP 2022549353 A5 JP2022549353 A5 JP 2022549353A5 JP 2022519324 A JP2022519324 A JP 2022519324A JP 2022519324 A JP2022519324 A JP 2022519324A JP 2022549353 A5 JP2022549353 A5 JP 2022549353A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- optionally substituted
- independently
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025165441A JP2025186528A (ja) | 2019-09-24 | 2025-10-01 | プロテインキナーゼc(pkc)に作用するジテルペノイド化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962905253P | 2019-09-24 | 2019-09-24 | |
| US62/905,253 | 2019-09-24 | ||
| PCT/US2020/052545 WO2021062030A1 (en) | 2019-09-24 | 2020-09-24 | Diterpenoid compounds that act on protein kinase c (pkc) |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025165441A Division JP2025186528A (ja) | 2019-09-24 | 2025-10-01 | プロテインキナーゼc(pkc)に作用するジテルペノイド化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022549353A JP2022549353A (ja) | 2022-11-24 |
| JP2022549353A5 true JP2022549353A5 (cg-RX-API-DMAC10.html) | 2023-09-06 |
| JP7753201B2 JP7753201B2 (ja) | 2025-10-14 |
Family
ID=75165333
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022519324A Active JP7753201B2 (ja) | 2019-09-24 | 2020-09-24 | プロテインキナーゼc(pkc)に作用するジテルペノイド化合物 |
| JP2025165441A Pending JP2025186528A (ja) | 2019-09-24 | 2025-10-01 | プロテインキナーゼc(pkc)に作用するジテルペノイド化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025165441A Pending JP2025186528A (ja) | 2019-09-24 | 2025-10-01 | プロテインキナーゼc(pkc)に作用するジテルペノイド化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220411362A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4041268A4 (cg-RX-API-DMAC10.html) |
| JP (2) | JP7753201B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR20220116143A (cg-RX-API-DMAC10.html) |
| CN (1) | CN114786697A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2020352641B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3155650A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL291697B2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021062030A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3212440A1 (en) * | 2021-03-23 | 2022-09-29 | Ruihong Chen | Diterpenoid compounds that act on protein kinase c (pkc) |
| WO2023033128A1 (ja) * | 2021-09-03 | 2023-03-09 | 国立大学法人京都大学 | タンパク質の製造方法 |
| JP2025505797A (ja) * | 2022-02-17 | 2025-02-28 | キューバイオティクス プロプライアタリー リミティド | 併用療法 |
| WO2025226622A1 (en) * | 2024-04-22 | 2025-10-30 | The Board Of Trustees Of The Leland Stanford Junior University | Tigilanol tiglate analogs, phorbol analogs, prodrugs, synthetic methods, and methods of use |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6063814A (en) | 1997-04-14 | 2000-05-16 | Chang; Richard L. | Phorbol esters as anti-neoplastic and white blood cell elevating agents |
| JP2008051589A (ja) * | 2006-08-23 | 2008-03-06 | Shiseido Co Ltd | ホルボール抗原 |
| US8816122B2 (en) * | 2009-07-20 | 2014-08-26 | The Board Of Trustees Of The Leland Stanford Junior University | Prostratin analogs, bryostatin analogs, prodrugs, synthetic methods, and methods of use |
| WO2013071282A1 (en) * | 2011-11-13 | 2013-05-16 | Blanchette Rockefeller Neurosciences Institute | Pkc activators and combinations thereof |
| BR112014017716A8 (pt) | 2012-01-18 | 2021-03-02 | Biosuccess Biotech Co Ltd | composições de ésteres de forbol, métodos para prevenir ou tratar acidente vascular cerebral e uso de ésteres de forbol |
| AU2015314979A1 (en) * | 2014-09-10 | 2017-03-02 | The Regents Of The University Of California | Targeting K-Ras-mediated signaling pathways and malignancy by prostratin |
| MA40904A (fr) | 2014-11-03 | 2017-09-12 | Hygeia Tech Inc | Compositions d'ester de phorbol et procédés pour traiter ou réduire la durée d'une cytopénie |
| WO2017062924A1 (en) * | 2015-10-08 | 2017-04-13 | Alkon Daniel L | Dosing regimens of pkc activators |
| US10722484B2 (en) * | 2016-03-09 | 2020-07-28 | K-Gen, Inc. | Methods of cancer treatment |
| CA3212440A1 (en) * | 2021-03-23 | 2022-09-29 | Ruihong Chen | Diterpenoid compounds that act on protein kinase c (pkc) |
-
2020
- 2020-09-24 AU AU2020352641A patent/AU2020352641B2/en active Active
- 2020-09-24 US US17/763,611 patent/US20220411362A1/en active Pending
- 2020-09-24 EP EP20867438.2A patent/EP4041268A4/en active Pending
- 2020-09-24 WO PCT/US2020/052545 patent/WO2021062030A1/en not_active Ceased
- 2020-09-24 KR KR1020227013445A patent/KR20220116143A/ko active Pending
- 2020-09-24 IL IL291697A patent/IL291697B2/en unknown
- 2020-09-24 JP JP2022519324A patent/JP7753201B2/ja active Active
- 2020-09-24 CA CA3155650A patent/CA3155650A1/en active Pending
- 2020-09-24 CN CN202080081644.1A patent/CN114786697A/zh active Pending
-
2025
- 2025-10-01 JP JP2025165441A patent/JP2025186528A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025160318A5 (cg-RX-API-DMAC10.html) | ||
| ES2657014T3 (es) | Péptidos citotóxicos y conjugados de fármaco anticuerpo de los mismos | |
| JP2025160317A5 (cg-RX-API-DMAC10.html) | ||
| RU2662951C2 (ru) | Производные доластатина 10 и ауристатинов | |
| CA2935077C (en) | Sulfonamide-containing linkage systems for drug conjugates | |
| JP2021152063A5 (cg-RX-API-DMAC10.html) | ||
| ES3013661T3 (en) | Affinity medicant conjugates | |
| IL291697B2 (en) | Diterpenoid compounds acting on protein kinase (pkc c) | |
| JPWO2020122034A5 (cg-RX-API-DMAC10.html) | ||
| JP2022537158A5 (cg-RX-API-DMAC10.html) | ||
| HUT72440A (en) | Imidazole-containing inhibitors of farnesyl protein transferase and pharmaceutical compositions containing them | |
| IL108999A (en) | Nitrogen-containing heterocyclic compounds and pharmaceutical compositions containing the same | |
| JP2016505513A5 (cg-RX-API-DMAC10.html) | ||
| HRP20220550T1 (hr) | Imunokonjugati koji ciljaju adam9 i postupci njihove uporabe | |
| JP2018058822A5 (cg-RX-API-DMAC10.html) | ||
| JP7334147B2 (ja) | 炭酸脱水酵素陽性がんを標的とするfbsa系治療および放射性造影複合体 | |
| WO2000044770A1 (en) | Substituted phenethylamine derivatives | |
| JP2017518363A5 (cg-RX-API-DMAC10.html) | ||
| JPH0523260B2 (cg-RX-API-DMAC10.html) | ||
| JP2022546807A5 (cg-RX-API-DMAC10.html) | ||
| JP2016536372A5 (cg-RX-API-DMAC10.html) | ||
| ES2883023T3 (es) | Derivados de péptidos de dolaproína-dolaisoleuina citotóxicos para el tratamiento del cáncer | |
| JP2026501817A (ja) | リガンド-薬物コンジュゲート | |
| JP2024512046A5 (cg-RX-API-DMAC10.html) | ||
| RU2008152813A (ru) | Пептиды с антипролиферативной активностью |